Global Health in Crisis: Challenges and Options for Action
Summary
This briefing paper argues that the global health system is in a structural crisis driven by declining public funding and the rising dominance of private actors, which prioritises profit over the human right to health. It concludes that a just global health order requires strengthening the WHO, limiting private-sector influence, and treating essential medicines as public goods.
Key insights
- The global health system is facing a funding crisis, with the OECD estimating that Official Development Assistance (ODA) for health will fall by up to 29 per cent in 2025 compared with 2024, potentially returning funding levels to those of the mid-2000s.
- The pharmaceutical industry uses 'evergreening' and 'patent thickets' to extend monopolies beyond the intended 20 years; for example, Roche has created around 100 patents for HER2-positive breast cancer therapies, extending some monopolies into the 2040s and generating over 156 billion Swiss francs.
- Private-sector lobbying significantly influences the World Health Organization (WHO), with US spending on WHO-related lobbying averaging 14.2 million US dollars per year between 2016 and 2019, rising to approximately 46 million US dollars during the COVID-19 pandemic.
- Philanthropic foundations, particularly the Gates Foundation, distort global health priorities by favouring technology-oriented 'quick wins' and vertical programmes for infectious diseases over structural health system strengthening and non-communicable diseases.
- The Gates Foundation is the WHO's largest donor, funding around 13 per cent of the 2024–2025 budget (761 million US dollars), which allows it to directly influence how the organization uses its resources through earmarked funds.
- Market-based financing instruments, such as IFFIm vaccine bonds, result in the 'privatisation of profits whilst simultaneously socialising risks', where private investors from the Global North received over 879 million US dollars in interest over 13 years paid from government development aid.
- Global health policy is increasingly 'verticalised' and 'medicalised', focusing on technical solutions like gene-drive mosquitoes for malaria rather than addressing structural causes of disease such as poverty, inequality, and climate change.
- Civil society organizations face a 'shrinking space' and are increasingly excluded from WHO decision-making processes through limited delegation sizes and the shift of discussions to informal, non-public meetings.
Cite the original document
- APA
- Seitz, K. (2026). Global Health in Crisis: Challenges and Options for Action. Misereor. https://www.misereor.org/fileadmin/user_upload_misereororg/publication/en/Global_Health_in_Crisis_Role_of_Private_Actors_2026.pdf
- Chicago
- Seitz, Karolin. Global Health in Crisis: Challenges and Options for Action. Misereor, 2026. https://www.misereor.org/fileadmin/user_upload_misereororg/publication/en/Global_Health_in_Crisis_Role_of_Private_Actors_2026.pdf.
- Wikipedia
- {{cite report |last1=Seitz |first1=Karolin |title=Global Health in Crisis: Challenges and Options for Action |publisher=Misereor |date=May 2026 |url=https://www.misereor.org/fileadmin/user_upload_misereororg/publication/en/Global_Health_in_Crisis_Role_of_Private_Actors_2026.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document misereor-000123)}}
- BibTeX
- @techreport{seitz2026global, author = {Seitz, Karolin}, title = {{Global Health in Crisis: Challenges and Options for Action}}, institution = {Misereor}, year = {2026}, month = may, url = {https://www.misereor.org/fileadmin/user_upload_misereororg/publication/en/Global_Health_in_Crisis_Role_of_Private_Actors_2026.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document misereor-000123} }
Full text
Collected · Record updated